GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Optima Medical Innovations Corp (OTCPK:TOKIF) » Definitions » EV-to-Revenue

Optima Medical Innovations (Optima Medical Innovations) EV-to-Revenue : 0.00 (As of Jun. 14, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Optima Medical Innovations EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Optima Medical Innovations's enterprise value is $0.00 Mil. Optima Medical Innovations's Revenue for the trailing twelve months (TTM) ended in Sep. 2021 was $1.94 Mil. Therefore, Optima Medical Innovations's EV-to-Revenue for today is 0.00.

The historical rank and industry rank for Optima Medical Innovations's EV-to-Revenue or its related term are showing as below:

TOKIF's EV-to-Revenue is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.84
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-14), Optima Medical Innovations's stock price is $0.0001. Optima Medical Innovations's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2021 was $0.01. Therefore, Optima Medical Innovations's PS Ratio for today is 0.01.


Optima Medical Innovations EV-to-Revenue Historical Data

The historical data trend for Optima Medical Innovations's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optima Medical Innovations EV-to-Revenue Chart

Optima Medical Innovations Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Dec19 Dec20
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 382.17 991.11 1.52 0.70

Optima Medical Innovations Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.94 0.70 1.31 2.22 2.28

Competitive Comparison of Optima Medical Innovations's EV-to-Revenue

For the Medical Care Facilities subindustry, Optima Medical Innovations's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optima Medical Innovations's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Optima Medical Innovations's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Optima Medical Innovations's EV-to-Revenue falls into.



Optima Medical Innovations EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Optima Medical Innovations's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.000/1.942
=0.00

Optima Medical Innovations's current Enterprise Value is $0.00 Mil.
Optima Medical Innovations's Revenue for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optima Medical Innovations  (OTCPK:TOKIF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Optima Medical Innovations's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0001/0.009
=0.01

Optima Medical Innovations's share price for today is $0.0001.
Optima Medical Innovations's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optima Medical Innovations EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Optima Medical Innovations's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Optima Medical Innovations (Optima Medical Innovations) Business Description

Traded in Other Exchanges
N/A
Address
5460 Yonge Street, Unit 209, Toronto, ON, CAN, M2N 6K7
Optima Medical Innovations Corp delivers pathways to innovative, science-based health and wellness solutions. It focuses on multi-disciplinary pain management. The group is also engaged in the development of solutions, products and treatments for pain relief, wellness and Cancer therapy.